Welcome to our dedicated page for Asahi Kaisei Adr news (Ticker: AHKSY), a resource for investors and traders seeking the latest updates and insights on Asahi Kaisei Adr stock.
Asahi Kasei reports developments across a diversified global business that includes healthcare, materials, electronic components, and hydrogen-related technologies. News commonly covers pharmaceutical pipeline expansion, specialty pharmaceutical acquisitions, antiviral and autoimmune-disease programs, and subsidiary activity involving Veloxis Pharmaceuticals, Asahi Kasei Therapeutics, and Asahi Kasei Pharma.
Company updates also include Asahi Kasei Microdevices' magnetic-sensor and photonic technology work, chlor-alkali electrolysis products such as electrolyzer cells, ion-exchange membranes, and electrodes, and Aqualyzer™ alkaline-water electrolyzer deployments for hydrogen production. Recurring themes include research collaborations, license agreements, clinical and regulatory disclosures, material agreements, capital-structure updates, and operating and financial results.
Asahi Kasei showcased their new AKXY2 concept car at CES 2023, emphasizing solutions for sustainable mobility. The vehicle features innovations like Active Road Noise Cancellation, millimeter-wave radar for child detection, and drunk driving prevention systems. The company highlighted its commitment to sustainability, integrating recycled materials and advanced technologies in the automotive sector. AKXY2 proposes a 'mobile living space' concept, aligning with modern consumer demands for comfort and eco-friendliness.
Asahi Kasei has announced the sale of Tufdene™ S-SBR and Asadene™ BR, produced using the mass-balance method, starting November 2022. The products, certified under ISCC PLUS, aim to meet the growing demand for sustainable materials, particularly for eco-friendly tires. Asahi Kasei plans to reduce CO2 emissions by integrating biomass and plastic waste in production. The company seeks to become a sustainable partner for customers while striving for carbon neutrality by 2050.
Asahi Kasei has acquired ISCC PLUS certification for several products, allowing it to manage biomass and recycled materials using the mass-balance method across its supply chain. The certified products include Acrylonitrile, Methyl methacrylate, and various types of rubber and plastic. This certification aligns with the company’s commitment to sustainability and carbon neutrality, enhancing its product offerings to meet global demands for eco-friendly solutions. Asahi Kasei aims to deepen collaboration with partners and further its sustainability goals.
Asahi Kasei has begun constructing an alkaline water electrolysis pilot test plant for hydrogen production at its Kawasaki Works in Japan, expected to commence operations in early 2024. This project, supported by Japan's NEDO, aims to enhance the efficiency of electrolysis equipment to adapt to renewable energy power fluctuations. With a focus on hydrogen as a strategic growth area, Asahi Kasei plans to commercialize larger alkaline water electrolysis systems by 2025, building on its previous trials since 2020.
Summary not available.
Summary not available.
Asahi Kasei Pharma is inviting proposals for drug development research, offering funding of up to US$200,000 annually for selected applications over a period of 1-3 years. The application window runs from January 5, 2023 to February 28, 2023. The focus areas include autoimmune, renal, neurodegenerative, and bone diseases, alongside platform technologies for drug discovery. Established in 2016, Asahi Kasei Pharma has funded over 20 proposals and aims to foster innovation through collaborations with global researchers.
Asahi Kasei and Crystal IS have reported that their experimental Klaran™ WR UVC LED water treatment reactor outperformed traditional mercury lamp systems by over 75% in bacterial performance tests. The reactor operates at the same power level (6 W) while being lighter, smaller, and safer, contributing to a mercury-free environment. This advancement aligns with the stricter regulations following the Minamata Convention, promoting energy efficiency and safer water treatment. Asahi Kasei aims to replace mercury lamps with UVC LEDs in various applications.
Asahi Kasei is launching new grades of XYRON™ modified polyphenylene ether (mPPE) to enhance 5G applications in North America and Europe. These materials offer improved connectivity, lighter weight, and higher heat resistance than traditional metals. Key features include low dielectric permittivity and high hydrolysis resistance, resulting in better efficiency for 5G smartphone antennas and base stations. The new recycled PET/PPE alloys utilize 40% post-consumer materials, supporting sustainability. XYRON™ will be showcased at K 2022 in Düsseldorf from October 19-26.
Asahi Kasei has announced a trial to test its K-GIS zeolite adsorbent for purifying biogas at Kurashiki City's sewage treatment plant. The System aims to efficiently separate CO2 from biogas, generating high-purity biomethane. Aiming for operational launch by the end of 2023, the project aligns with the company's carbon neutrality goals. The partnership with Kurashiki City emphasizes the importance of decarbonization. If effective, this technology could lead to a carbon-negative cycle through carbon capture, utilization, or storage.